Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis have?
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis has 2,067 citations in the OpenAlex counts ScholarIQ stores.
When was Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis published?
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis has 2016 year in the ScholarIQ index.
What is the open-access status of Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis?
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis has bronze oa status in the ScholarIQ index.
What is the DOI of Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis?
The DOI for Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis is on the source record.
What is the PMID of Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis?
The PMID for Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis is on the source record.
What is the OpenAlex record for Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis?
The OpenAlex for Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis is on the source record.